Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Investig Med High Impact Case Rep ; 10: 23247096211051928, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35225034

RESUMO

A 49-year-old man with no significant past medical history received dexamethasone as part of his treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Less than 3 weeks later, the patient developed acute respiratory distress syndrome. Radiological and serological testing led to a diagnosis of acute hypoxic miliary coccidioidomycosis. A 52-year-old man with a past medical history of chronic kidney disease (CKD) was treated with prednisone for focal segmental glomerulosclerosis (FSGS). Within 2 weeks, this patient developed bilateral lower extremity weakness. Radiology, serology, and lumbar puncture proved a diagnosis of reactivated coccidioidomycosis with miliary pattern and coccidioidomycosis meningoencephalitis with arachnoiditis. Whether treatment with glucocorticoids caused reactivation of coccidioidomycosis is discussed in this case series.


Assuntos
Tratamento Farmacológico da COVID-19 , Coccidioidomicose , Síndrome do Desconforto Respiratório , Coccidioidomicose/diagnóstico , Coccidioidomicose/tratamento farmacológico , Glucocorticoides/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Síndrome do Desconforto Respiratório/induzido quimicamente , SARS-CoV-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...